Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.065
Sell
RSI(14)
31.983
Neutral
STOCH(KDJ)(9,3,3)
8.655
Oversold
ATR(14)
0.144
Low Volatility
CCI(14)
-82.523
Neutral
Williams %R
95.652
Oversold
TRIX(12,20)
-1.321
Sell
StochRSI(14)
70.317
Buy
Search
Ainos Inc
AIMDAdd to Watchlist
1.335USD
-0.025-1.84%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.15MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.84%
5 Days
-4.64%
1 Month
-31.19%
6 Months
-33.25%
Year to Date
-18.60%
1 Year
-48.65%
Key Figures
1.380Open
1.415High
19.34KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.32%Turnover Ratio
1.360Prev. Close
1.330Low
21.15KTurnover
LossP/E Static
1.43P/B
0.00%Div Yield TTM
-57.58%ROA
4.50052wk High
0.65Volume Ratio
-14.86MNet Profit
6.11MShares
-2.8307EPS TTM
2.27Beta
-148.24%ROE
1.26052wk Low
6.25%Amplitude
-373.91%Gross Margin
8.15MMarket Cap
-3.15Reward/Risk
8.66%Risk Rate
TradingKey Stock Score of Ainos Inc
Currency: USD Updated: 2026-07-31Key Insights
Ainos Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 210 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Ainos Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Ainos Inc Highlights
StrengthsRisks
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Growing
The company is in a growing phase, with the latest annual income totaling USD 124.16K.
Fairly Valued
The company’s latest PE is -0.47, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 300.01K shares, increasing 30.26% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.90.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Ainos Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.330
Buy
MA10
1.425
Sell
MA20
1.643
Sell
MA50
1.869
Sell
MA100
1.743
Sell
MA200
1.996
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Ainos Inc Info
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Ticker SymbolAIMD
CompanyAinos Inc
CEOTsai (Chun-Hsien)
Websitehttps://www.ainos.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Ainos Inc (AIMD)?
The current price of Ainos Inc (AIMD) is 1.33.
What is the symbol of Ainos Inc?
The ticker symbol of Ainos Inc is AIMD.
What is the 52-week high of Ainos Inc?
The 52-week high of Ainos Inc is 4.50.
What is the 52-week low of Ainos Inc?
The 52-week low of Ainos Inc is 1.26.
What is the market capitalization of Ainos Inc?
The market capitalization of Ainos Inc is 8.15M.
What is the Earnings Per Share (EPS TTM) of Ainos Inc (AIMD)?
The Earnings Per Share (EPS TTM) of Ainos Inc (AIMD) is -3.46.